RT Journal Article
SR Electronic
T1 Prevalence and source analysis of COVID-19 misinformation of 138 countries
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.08.21256879
DO 10.1101/2021.05.08.21256879
A1 Al-Zaman, Md. Sayeed
YR 2021
UL http://medrxiv.org/content/early/2021/05/12/2021.05.08.21256879.abstract
AB This study analyzed 9,657 pieces of misinformation that originated in 138 countries and fact-checked by 94 organizations. Collected from Poynter Institute’s official website and following a quantitative content analysis method along with descriptive statistical analysis, this research produces some novel insights regarding COVID-19 misinformation. The findings show that India (15.94%), the US (9.74%), Brazil (8.57%), and Spain (8.03%) are the four most misinformation-affected countries. Based on the results, it is presumed that the prevalence of COVID-19 misinformation can have a positive association with the COVID-19 situation. Social media (84.94%) produces the highest amount of misinformation, and the internet (90.5%) as a whole is responsible for most of the COVID-19 misinformation. Moreover, Facebook alone produces 66.87% misinformation among all social media platforms. Of all countries, India (18.07%) produced the highest amount of social media misinformation, perhaps thanks to the country’s higher internet penetration rate, increasing social media consumption, and users’ lack of internet literacy. On the other hand, countries like Turkey, the US, Brazil, and the Philippines where either political control over media is intense or political conservatism is apparent, experienced a higher amount of misinformation from mainstream media, political figures, and celebrities. Although the prevalence of misinformation was the highest in March 2020, given the present trends, it may likely to increase slightly in 2021.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A